Clinical Trial Update: Corrected QT (QTc) Study With Flucticasone Furoate and GW642444 [Phase 1]

View source ↗

Summary

Completed Phase 1 QTc study assessing the cardiac safety of co-administering fluticasone furoate with GW642444 in asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• GW642444 (GW642444)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED